MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-WB-10-0000721
Alteus Biogenics Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹217.9 Cr
▲ 27% YoY
Net profit · FY 2025
₹4.37 Cr
Net margin 2%
EBITDA · FY 2025
₹7.16 Cr
EBITDA margin 3.3%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹41.5 Cr
Satisfied ₹12.5 Cr
Company age
18 yrs
Est. 2008
Employees · EPFO
292
Provident fund records
About Alteus Biogenics Private Limited
Data last updated:
Alteus Biogenics Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 May 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24100WB2008PTC125979. Its GSTIN is 19AAHCA0464C1Z0 (West Bengal). The company holds 10 GST registrations, all of them active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Nibedita Chakraborty and Soma Dev.
Its last annual general meeting (AGM) was held on 15 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 14B Dover Lane 1st Floor, Kolkata, West Bengal, India – 700029.
As per the financials filed for FY 2025, the company reported a revenue of ₹217.9 Cr, a growth of 27% compared to the previous year. For the same year it recorded a net profit of ₹4.37 Cr (net margin 2%) and EBITDA of ₹7.16 Cr (EBITDA margin 3.3%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 32% over five years.
The company has about 292 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹41.5 Cr and satisfied charges of ₹12.5 Cr on record. Court records list 4 cases involving the company, including 1 filed by the company and 3 filed against it; 1 case is pending. The company has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹1.15 Cr; the latest was in March 2023. Its 8 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 4 larger and 4 smaller; the largest is Pharmapoint (India) Private Limited with revenue of ₹222.83 Cr.
Alteus Biogenics Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0000721). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alteusbiogenics.com.
Company details
CIN U24100WB2008PTC125979
Registration Number 125979
Incorporation Date 22 May 2008
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 15 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-WB-10-0000721
Recognitions & Rankings of Alteus Biogenics
Contact details
Alteus Biogenics Private Limited's registered office is in Kolkata, West Bengal. Its website is alteusbiogenics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address14B Dover Lane 1st Floor, Kolkata, West Bengal, India – 700029
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Alteus Biogenics Private Limited, buy the company report.
Comprehensive company report
Alteus Biogenics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Alteus Biogenics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Alteus Biogenics Private Limited, buy the company report.
Financials of Alteus Biogenics Private Limited
FY 2025 filings availableAlteus Biogenics Private Limited reported revenue of ₹217.9 Cr (up 27% YoY) for FY 2025.
Revenue · FY 2025
₹217.9 Cr ▲ 27%
Net profit · FY 2025
₹4.37 Cr margin 2%
EBITDA · FY 2025
₹7.16 Cr margin 3.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 27%
3 years · compounded
▲ 28%
5 years · compounded
▲ 32%
EBITDA CAGR growth
1 year
▼ 24%
3 years · compounded
▼ 6%
5 years · compounded
▲ 17%
Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 27% growth in the latest year. EBITDA fell 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.16 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.37 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.3% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alteus Biogenics Private Limited, buy the company report.
Board of directors of Alteus Biogenics Private Limited
Alteus Biogenics has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nibedita Chakraborty | Director | 01 Jan 2014 | 12 Years 9 Months | Current |
| Soma Dev | Director | 01 Jan 2014 | 12 Years 9 Months | Current |
| Debasish Mitra | Director | 22 May 2008 | 18 Years 5 Months | Current |
| Reetwija Chakraborty Also directs: Mrittika Production Pvt Ltd | Director | 01 Jan 2014 | 12 Years 9 Months | Current |
| Abesh Mazumder Also directs: Aura Agencies Private Limited, Stance Biogenics Private Limited, Delon Distribution and Logistics Private Limited and 1 more | Director | 26 May 2008 | 18 Years 5 Months | Current |
Peer comparison
Alteus Biogenics Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pharmapoint (India) Private Limited | ₹222.83 Cr (FY 2025) | 19.0% | Mumbai, Maharashtra, India | |||
| Workcell Solutions Private Limited | ₹221.81 Cr (FY 2025) | 46.0% | Mumbai, Maharashtra, India | |||
| Adeline Pharma Private Limited | ₹221.13 Cr (FY 2023) | -6.0% | Hyderabad, Telangana, India | |||
| D Vijay Pharma Private Limited | ₹219.42 Cr (FY 2025) | 23.0% | Nashik, Maharashtra, India | |||
| Alteus Biogenics Private Limitedthis company | ₹217.9 Cr (FY 2025) | ₹4.37 Cr | 2% | 27.0% | 292 | Kolkata, West Bengal, India |
| Vasu Vaccines and Speciality Drugs Hyd Private Limited | ₹215.31 Cr (FY 2025) | 1.0% | Hyderabad, Telangana, India | |||
| Shreeji Distributors Pharma Private Limited | ₹214.34 Cr (FY 2025) | 5.0% | Mumbai, Maharashtra, India | |||
| Gobinda Distributors Private Limited | ₹212.92 Cr (FY 2025) | 15.0% | Kolkata, West Bengal, India | |||
| Rahul Distributors Private Limited | ₹212.41 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Alteus Biogenics Private Limited, buy the company report.
Auditor
Alteus Biogenics Private Limited is audited by DAMLE DHANDHANIA & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DAMLE DHANDHANIA & CO | FY 2023 | 325361E |
Shareholding
The shareholding of Alteus Biogenics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Alteus Biogenics Private Limited, buy the company report.
Charges & borrowings
Open charges
₹41.5 Cr
Satisfied charges
₹12.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Dec 2023 | 100900220 | Hdfc Bank Limited | ₹30 Cr | Open | |
| 16 Sep 2015 | 10604296 | Deutsche Bank Ag | ₹34.38 Lakh | Open | |
| 15 Jan 2014 | 10473855 | Deutsche Bank Ag | ₹60 Lakh | Open | |
| 10 Jun 2013 | 10432330 | Hdfc Bank Limited | ₹10.5 Cr | Open | |
| 11 May 2012 | 10358815 | Union Bank of India | ₹6 Lakh | Open |
To see the full charge records of Alteus Biogenics Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Alteus Biogenics Private Limited has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹1.15 Cr; the latest was in March 2023.
Total deals
9
Secondary share transfers
6
Funding rounds
3
Disclosed funding
₹1.15 Cr
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2021 | Funding round | ₹70.8 Lakh | Investors: an individual |
| Mar 2017 | Funding round | ₹34.9 Lakh | Investors: an individual |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
To see the full deal history of Alteus Biogenics Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Alteus Biogenics Private Limited has 4 court cases on record: 1 filed by Alteus Biogenics, 3 filed against it. 1 case is pending and 3 are disposed.
Total cases
4
Filed by the company
1
Filed against the company
3
Pending
1
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
| High courts | 2 | 1 | 1 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (COMIP) | Filed against the company by Glenmark Pharmaceuticals Ltd | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Axis Bank Limited | Disposed |
| District court, Kamrup Metro, Assam | Court case (S 33 C -2 of I D Act) | Filed against the company by an individual | Disposed |
| Calcutta High Court | Writ petition | Filed by the company against State of West Bengal & Anr | Disposed |
To see the full case history of Alteus Biogenics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alteus Biogenics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Alteus Biogenics Private Limited has a workforce of 292 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
292
Active EPFO establishments
1
Employee growth
-67.45%
GST
Alteus Biogenics has 10 GST registrations: 10 active. The first 4 active GSTINs are listed below.
Total GSTINs
10
Active
10
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAHCA0464C1Z0 | West Bengal | Active | 01 Jul 2017 |
| 29AAHCA0464C1ZZ | Karnataka | Active | 01 Feb 2018 |
| 27AAHCA0464C1Z3 | Maharashtra | Active | 09 Feb 2018 |
| 06AAHCA0464C1Z7 | Haryana | Active | 01 Apr 2018 |
To see the full GST registrations and return filing status of Alteus Biogenics Private Limited, buy the company report.
Recent activity
Alteus Biogenics Private Limited has 10 board changes on record since 2008: 5 appointments and 5 cessations. The latest: Kabita Dutta ceased to be Director on 12 Jun 2023.
AGM
Alteus Biogenics Private Limited last Annual general meeting of members was held on 15 Sep 2025 as per latest MCA records.
Charges
A charge registered on 27 Mar 2023 via Charge ID 100697514 with Axis Bank Limited was fully satisfied on 18 May 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 3,000.00 Lakh registered on 20 Dec 2023 with Charge ID 100900220 was modified on 02 May 2025.
Filing
Alteus Biogenics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 3,000.00 Lakh with Charge ID 100900220 was registered on 20 Dec 2023.
Ceased
Kabita Dutta ceased to be Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 1,200.00 Lakh with Charge ID 100697514 was registered on 27 Mar 2023.
Charges
A charge with Hdfc Bank Limited of Rs. 1,050.00 Lakh registered on 10 Jun 2013 with Charge ID 10432330 was modified on 21 Dec 2022.
Charges
A charge with Deutsche Bank Ag amounted to Rs. 34.38 Lakh with Charge ID 10604296 was registered on 16 Sep 2015.
Ceased
Soumyen Basak ceased to be Additional Director.
Ceased
Sujit Kumar Banerjee ceased to be Additional Director.
Charges
A charge with Deutsche Bank Ag amounted to Rs. 60.00 Lakh with Charge ID 10473855 was registered on 15 Jan 2014.
13 earlier events are in the company report.
Frequently asked questions
Alteus Biogenics is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 May 2008 (18+ years old) and is registered under CIN U24100WB2008PTC125979.
Alteus Biogenics has 5 current directors:
- Nibedita Chakraborty - Director
- Soma Dev - Director
- Debasish Mitra - Director
- Reetwija Chakraborty - Director
- Abesh Mazumder - Director
The latest financial statements of Alteus Biogenics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 15 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Alteus Biogenics is 19AAHCA0464C1Z0, registered in West Bengal. The company has 10 GST registrations in all, of which 10 are active. Other active GSTINs include 29AAHCA0464C1ZZ (Karnataka), 27AAHCA0464C1Z3 (Maharashtra), 06AAHCA0464C1Z7 (Haryana).
The CIN (Corporate Identification Number) of Alteus Biogenics is U24100WB2008PTC125979. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alteus Biogenics has 4 court cases on record: 1 filed by the company and 3 filed against it. 1 is pending. Most are in the district courts.
Alteus Biogenics was incorporated on 22 May 2008, making it 18+ years old. It is registered with the Registrar of Companies, Kolkata.
Alteus Biogenics has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹1.15 Cr; the latest was in March 2023.
The peers of Alteus Biogenics by revenue are Pharmapoint (India) Private Limited, Workcell Solutions Private Limited, Adeline Pharma Private Limited, D Vijay Pharma Private Limited, Vasu Vaccines and Speciality Drugs Hyd Private Limited and 3 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Kabita Dutta ceased to be Director on 12 Jun 2023. Soumyen Basak ceased to be Additional Director on 19 May 2014. Sujit Kumar Banerjee ceased to be Additional Director on 17 May 2014. Alteus Biogenics has 10 board changes on record in total.
Yes, Alteus Biogenics is registered as a medium enterprise under Udyam registration (number: UDYAM-WB-10-0000721).